new glp 1 drugs 2025 ISPOR 2025: Exploring reasons for GLP-1 discontinuation Indications for GLP-1/GIP RA Summary

Our board-certified team sees patients across Arlington, Richardson, Dallas , and Texarkana

This episode will explain how to design the safest, most biologically effective, cost-effective supplementation protocol to meet your particular goals and support your overall health, including vitality and longevity

Lei L, Duker JS, Yoshida Y, et al

Make this luxurious lotion a staple in your beauty regime and experience the transformative benefits for yourself

In a clinical trial, participants with obesity (without diabetes) experienced an average weight loss of 20% with tirzepatide, compared to 13.7% with semaglutide after 72 weeks